Published in East Afr Med J on January 01, 2008
Cardiometabolic risk factors among HIV patients on antiretroviral therapy. Lipids Health Dis (2013) 1.02
Dyslipidemia in an HIV-positive antiretroviral treatment-naive population in Dar es Salaam, Tanzania. J Acquir Immune Defic Syndr (2011) 0.98
Metabolic abnormalities in adult HIV infected population on antiretroviral medication in Malaysia: a cross-sectional survey. BMC Public Health (2013) 0.96
Prevalence of dyslipidemia among HIV-infected patients using first-line highly active antiretroviral therapy in Southern Ethiopia: a cross-sectional comparative group study. AIDS Res Ther (2012) 0.92
Prevalence of lipodystrophy and metabolic syndrome among HIV positive individuals on Highly Active Anti-Retroviral treatment in Jimma, South West Ethiopia. Pan Afr Med J (2012) 0.90
Prevalence of HIV-Associated Metabolic Abnormalities among Patients Taking First-Line Antiretroviral Therapy in Uganda. ISRN AIDS (2012) 0.89
Cardiovascular disease risk factors among HIV-infected Nigerians receiving highly active antiretroviral therapy. Niger Med J (2013) 0.88
Glucose Metabolism Disorders, HIV and Antiretroviral Therapy among Tanzanian Adults. PLoS One (2015) 0.85
Assessment of cardiovascular risk factors in people with HIV infection treated with ART in rural South Africa: a cross sectional study. AIDS Res Ther (2015) 0.84
Evidence of increased blood pressure and hypertension risk among people living with HIV on antiretroviral therapy: a systematic review with meta-analysis. J Hum Hypertens (2015) 0.83
Association of increased upper trunk and decreased leg fat with 2-h glucose in control and HIV-infected persons. Diabetes Care (2011) 0.81
Risk Factors of Cardiovascular Diseases in HIV/AIDS Patients on HAART. Open AIDS J (2015) 0.79
Changes in blood pressure, glucose levels, insulin secretion and anthropometry after long term exposure to antiretroviral therapy in South African women. AIDS Res Ther (2015) 0.79
Highly active antiretroviral therapy and dyslipidemia in people living with HIV/AIDS in Fako Division, South West Region of Cameroon. BMC Cardiovasc Disord (2015) 0.78
Changes in coronary heart disease risk profiles of HIV patients in Zimbabwe over 9 months: a follow-up study. HIV AIDS (Auckl) (2016) 0.75
Dysglycemia associations with adipose tissue among HIV-infected patients after 2 years of antiretroviral therapy in Mwanza: a follow-up cross-sectional study. BMC Infect Dis (2017) 0.75
A Comparison of the Diabetes Risk Score in HIV/AIDS Patients on Highly Active Antiretroviral Therapy (HAART) and HAART-Naïve Patients at the Limbe Regional Hospital, Cameroon. PLoS One (2016) 0.75
Cardiovascular disease risk among Chinese antiretroviral-naïve adults with advanced HIV disease. BMC Infect Dis (2017) 0.75
Incidence and prevalence of type 2 diabetes mellitus with HIV infection in Africa: a systematic review and meta-analysis. BMJ Open (2017) 0.75
Association between highly active antiretroviral therapy and selected cardiovascular disease risk factors in sub-Saharan Africa: a systematic review and meta-analysis protocol. BMJ Open (2017) 0.75
Life-threatening bacteraemia in HIV-1 seropositive adults admitted to hospital in Nairobi, Kenya. Lancet (1990) 4.17
Prevalence of Helicobacter pylori and endoscopic findings in HIV seropositive patients with upper gastrointestinal tract symptoms at Kenyatta National Hospital, Nairobi. East Afr Med J (2002) 1.55
Structure of the N-terminal cellulose-binding domain of Cellulomonas fimi CenC determined by nuclear magnetic resonance spectroscopy. Biochemistry (1996) 1.51
The pKa of the general acid/base carboxyl group of a glycosidase cycles during catalysis: a 13C-NMR study of bacillus circulans xylanase. Biochemistry (1996) 1.43
Extrapulmonary and disseminated tuberculosis in HIV-1-seropositive patients presenting to the acute medical services in Nairobi. AIDS (1990) 1.40
Cooperativity of the MUC1 oncoprotein and STAT1 pathway in poor prognosis human breast cancer. Oncogene (2009) 1.24
Interaction of soluble cellooligosaccharides with the N-terminal cellulose-binding domain of Cellulomonas fimi CenC 2. NMR and ultraviolet absorption spectroscopy. Biochemistry (1996) 1.14
Total lymphocyte count as a surrogate marker for CD4+ t cell count in initiating antiretroviral therapy at Kenyatta National Hospital, Nairobi. East Afr Med J (2007) 0.95
Endoscopic findings and the prevalence of Helicobacter pylori in chronic renal failure patients with dyspepsia. East Afr Med J (2000) 0.95
Colonoscopic findings in Kenyan African patients. East Afr Med J (1998) 0.91
Prevalence of HCV and HCV/HIV co-infection among in-patients at the Kenyatta National Hospital. East Afr Med J (2005) 0.90
The prevalence of hepatitis C virus antibodies in renal patients, blood donors and patients with chronic liver disease in Kenya. East Afr Med J (1995) 0.85
HBV markers (HBsAg, HBSAb, HBCAb in 160 medical students at Kenyatta National Hospital. East Afr Med J (1989) 0.84
Stability and oligosaccharide binding of the N1 cellulose-binding domain of Cellulomonas fimi endoglucanase CenC. Biochemistry (1998) 0.81
The presentation and outcome of HIV-related disease in Nairobi. Q J Med (1992) 0.80
Cardiovascular features in adolescents and adults with sickle cell anaemia. East Afr Med J (1993) 0.80
Gastric carcinoma in the Kenyan African population. East Afr Med J (1991) 0.79
Acute coronary syndromes amongst type 2 diabetics with ischaemic electrocardiograms presenting to accident and emergency department of a Kenyan tertiary institution. East Afr Med J (2009) 0.78
The pattern of chronic gastric ulcer at Kenyatta National Hospital (K.N.H.). East Afr Med J (1989) 0.77
Correlation of WHO clinical staging with CD4 counts in adult HIV/AIDS patients at Kenyatta National Hospital, Nairobi. East Afr Med J (2011) 0.77
Duodenal ulcer disease at Kenyatta National Hospital. East Afr Med J (1985) 0.77
Prevalence of HCV and HIV/HCV co-infection among volunteer blood donors and VCT clients. East Afr Med J (2005) 0.76
Synthesis of alpha-amyrin derivatives and their in vivo antihyperglycemic activity. Eur J Med Chem (2008) 0.76
To observe the association between the staple Ethiopian diets and cancer of the oesophagus. East Afr Med J (2006) 0.75
Cardiovascular risk factors in patients with type 2 diabetes mellitus in Kenya: levels of control attained at the Outpatient Diabetic Clinic of Kenyatta National Hospital, Nairobi. East Afr Med J (2006) 0.75
Serum pepsinogen I in relation to some clinical features and complications of duodenal ulcer disease. East Afr Med J (1989) 0.75
Evaluation of culture media and antimicrobial susceptibility of Helicobacter pylori. East Afr Med J (1991) 0.75
Some aspects of obstructive jaundice at Kenyatta National Hospital. East Afr Med J (1989) 0.75
Properties and kinetics and purified brain hexokinase. Arch Biochem Biophys (1968) 0.75
Upper gastrointestinal tract in chronic renal failure as seen at Kenyatta National Hospital, Kenya. East Afr Med J (1988) 0.75
Famotidine in the management of gastro-oesophageal reflux. East Afr Med J (1994) 0.75
Upper gastrointestinal findings in diabetic outpatients at Kenyatta National Hospital, Nairobi. East Afr Med J (2002) 0.75
Cholelithiasis in the Kenyan African. East Afr Med J (1990) 0.75
Cryptococcal hepatitis and meningitis in a patient with acquired immunodeficiency syndrome: a case report. East Afr Med J (1989) 0.75
Sclerotherapy in the treatment of bleeding oesophageal varices: preliminary report. East Afr Med J (1988) 0.75
Helicobacter pylori: an infectious agent in peptic ulcer disease? East Afr Med J (1991) 0.75
Familial clustering of cancer in two tertiary care hospitals in Nairobi, Kenya. East Afr Med J (2010) 0.75
Hypertension over a 4-year-period at Kenyatta National Hospital (KNH). East Afr Med J (1985) 0.75
Spontaneous bacterial peritonitis. East Afr Med J (2004) 0.75
Peptic ulcer disease at Kenyatta National Hospital: an endoscopic experience. East Afr Med J (1987) 0.75
Platelet functions in patients with meningococcal meningitis at the Kenyatta National Hospital, Nairobi. East Afr Med J (2002) 0.75
The prevalence of hepatitis B surface antigen (HBsAg), anti-hepatitis B surface (anti-HBs) and anti-hepatitis B core (anti-HBc) in patients with acquired immuno-deficiency syndrome (AIDS). East Afr Med J (1990) 0.75
Hepatitis E virus. East Afr Med J (2009) 0.75
Fertility rate of epileptic women at Kenyatta National Hospital. East Afr Med J (2008) 0.75
Incidence of chemotherapy-related tumour lysis syndrome at Kenyatta National Hospital, Nairobi. East Afr Med J (2007) 0.75
Coronary artery disease and symptoms of depression in a Kenyan population. East Afr Med J (2004) 0.75
Helicobacter pylori eradication in peptic dyspepsia. East Afr Med J (2005) 0.75
The clinical pattern of duodenogastric bile reflux in the Kenyan Africans. East Afr Med J (1989) 0.75